Alzamend Neuro ALZN
NASDAQ ALZN
$1.37 +0.05 (+3.79%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alzamend Neuro (ALZN) Cash from Investing Activities (2020 - 2025)

Updated

Alzamend Neuro (ALZN) posted Cash from Investing Activities of -$210,000 for fiscal Q4 2025 (quarter ended Apr 30, 2025).

Analysis

Alzamend Neuro (ALZN) Cash from Investing Activities (2020 - 2025) Analysis & Trends

For FY2025 (ended Apr 30, 2025), Alzamend Neuro's Cash from Investing Activities came in at -$300,000.

  • In prior fiscal years, Alzamend Neuro's Cash from Investing Activities was -$147,243 in FY2024, -$106,458 in FY2022 and $100,915 in FY2021 (-3.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Alzamend Neuro 6.61 Mn 6.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2025 -210,000.00
Jul 31, 2024 -90,000.00
Jul 31, 2023 -147,243.00
Jul 31, 2020 100,915.00
API Access

Alzamend Neuro Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ALZN&period=max&api_key=YOUR_API_KEY